Cresp 200mcg Darbepoetin ALFA Injection

Cresp 200mcg Darbepoetin Alfa Injection is a prescription medication used to treat anemia associated with chronic kidney disease (CKD) and anemia resulting from certain chemotherapy treatments. It contains Darbepoetin Alfa, a long-acting erythropoiesis-stimulating agent (ESA) that works by stimulating the bone marrow to produce more red blood cells. By increasing red blood cell levels, Cresp 200mcg Darbepoetin Alfa Injection helps improve oxygen delivery throughout the body, reducing symptoms such as fatigue, weakness, dizziness, and shortness of breath. Administered as a subcutaneous or intravenous injection under the supervision of a healthcare professional, it is an important treatment option for managing anemia and improving quality of life. Regular monitoring of hemoglobin levels is essential during therapy to ensure safe and effective use. Patients should use Cresp 200mcg Injection only as prescribed by their healthcare provider.